Data Sources

Second Look Cancer relies primarily on public clinical trial registry records, especially ClinicalTrials.gov, for identifiers, titles, sponsors, recruitment statuses, locations, official descriptions, eligibility criteria, arms, interventions, and study dates.

ClinicalTrials.gov records are submitted and maintained by study sponsors or investigators. Second Look Cancer may reformat, summarize, classify, filter, or otherwise modify registry information to make it easier to review, so users should verify important details against the original record.

Where available and relevant, trial pages and educational content may reference sponsor or site materials, publications, PubMed-indexed literature, conference abstracts or presentations, public oncology education materials, regulatory labels, and credible public announcements.

Supporting sources are used to add context, such as how a treatment is described, whether public readouts exist, or what questions a patient may want to ask. They do not replace the official registry record, site staff, sponsor, or oncology team.

Public trial information can change quickly. Recruitment status, eligibility criteria, locations, contacts, sponsor details, and timelines may be delayed, incomplete, corrected, or different from what a study site can currently offer.

Second Look Cancer updates and reviews source-derived information, but it does not guarantee that every record is complete, accurate, current, or applicable to a specific person.

Treat Second Look Cancer as an informational layer for discovery, organization, and preparation. Before making any medical or enrollment decision, confirm details with the original source record, the trial site or sponsor, and your oncology team.

When we display registry-derived information, users should assume it may have been processed for readability, filtering, or summarization. ClinicalTrials.gov should be attributed as the source for registry data where applicable.